By Rudy Kratz On October 18, 2011, the European Union's Court of Justice ruled
that certain stem cell procedures requiring the destruction of human
embryos are unpatentable. More specifically, the court ruled that under
EU law, patents may not be obtained for processes that require a base...
by Antoinette F. Konski
There are several emerging technology clusters in the
induced pluripotent stem cell (iPSC) space. Simon Elliot and I conducted a
patent landscape analysis focusing on issued U.S. patents and pending
applications. We found several geographical clusters and a trend in the...